Saptak Chem And Business Ltd (SCBL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Saptak Chem And Business Ltd on NSE and BSE, with an AI summary of each filing.
Un-Audited Financial Results along with Statutory Auditors Limited Review Report for the Quarter ended September 30, 2026
Financial Result · 29 Oct 2026, 12:11 am
Saptak Chem and Business Reports Q2 FY27 Net Loss Amid Zero Revenue Saptak Chem and Business reported zero revenue from operations for the quarter ended 30th Sep'26, unchanged YoY and QoQ. Net loss narrowed to Rs 1.47 lakh compared to a loss of Rs 1.89 lakh in Q2 FY26 and Rs 4.85 lakh in Q1 FY27, driven by total expenses of Rs 1.47 lakh. Basic and diluted EPS stood at negative Rs 0.05. For H1 FY27, net loss was Rs 6.32 lakh versus Rs 7.79 lakh YoY. Net cash used in operating activities stood at Rs 182.46 lakh.
Un-Audited Financial Results along with Auditors Limited Review Report for the Quarter ended September 30, 2026
Outcome · 29 Oct 2026, 12:05 am
Saptak Chem and Business Reports Nil Revenue and Reduced Losses for Q2 FY27 Saptak Chem and Business reported nil revenue from operations for the quarter ended 30th Sep'26, unchanged YoY and QoQ. Net loss narrowed to Rs 1.47 lakh from Rs 1.89 lakh in Q2 FY26 and Rs 4.85 lakh in Q1 FY27, driven by total expenses of Rs 1.47 lakh. Basic and diluted EPS stood at Rs (0.05). For H1 FY27, net loss was Rs 6.32 lakh on zero revenue. Paid-up equity share capital increased to Rs 307.32 lakh following capital reduction adjustments and share allotments.
Saptak Chem And Business Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/10/2026 ,inter alia, to consider and approve Results for Quarter ....
Intimation · 24 Oct 2026, 5:30 am
Saptak Chem and Business Board to Consider Q2 FY27 Results on 24th Oct'26 Saptak Chem and Business Limited has scheduled a meeting of its Board of Directors on 24th Oct'26 at its registered office. The board will primarily consider and approve the unaudited financial results of the company for the quarter and half-year ended 30th Sep'26, along with the Auditor's Limited Review Report.
AGM Voting Results
Annual General Meeting · 31 Aug 2026, 11:04 pm
Proceedings of AGM
Annual General Meeting · 29 Aug 2026, 8:00 pm
Corringendum to AGM
Annual General Meeting · 18 Aug 2026, 12:08 am
Annual Report 2025-26
Others (Uncategorized) · 06 Aug 2026, 12:29 am
Notice of AGM
Annual General Meeting · 06 Aug 2026, 12:19 am
Reg 32
Others (Uncategorized) · 01 Aug 2026, 11:55 pm
Saptak Chem: No Deviation in Use of Preferential Issue Proceeds Saptak Chem and Business Limited confirmed no deviation in utilizing funds from its preferential issue of convertible warrants for the quarter ended 30 Jun'26. The company raised Rs 4.20 crore via the issuance of 40 lakh warrants at Rs 10.50 each. As of the reporting date, it has received Rs 1.05 crore (25% consideration) and utilized Rs 1.57 crore towards working capital requirements. The Audit Committee reviewed the utilization statement and noted no variations from the stated objectives.
Quarterly Results June 30, 2026
Financial Result · 01 Aug 2026, 11:01 pm
Saptak Chem Reports Q1FY27 Loss, Appoints New Managing Director Saptak Chem and Business Ltd reported a net loss of Rs. 4.85 lakhs for Q1FY27, ending 30 Jun'26, compared to a loss of Rs. 5.90 lakhs YoY. Revenue from operations was nil. The company's board approved the appointment of Mr. Ayush Tated as the new Managing Director. Additionally, the 47th Annual General Meeting (AGM) has been scheduled for 28 Aug'26 via video conferencing. The register of members will be closed from 22 Aug'26 to 28 Aug'26 for the purpose of the AGM.
Quarterly Results June 2026
Outcome · 01 Aug 2026, 10:55 pm
Saptak Chem And Business Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 0.0 ■ EBITDA: -4.9 (+17.8% YoY | +61.2% QoQ) ■ EBITDA Margin (%): 0.0 ■ PAT: -4.9 (+17.8% YoY | +61.2% QoQ) ■ EPS (INR): -0.16 (-220.0% YoY | +86.2% QoQ)
Saptak Chem And Business Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve Unaudited Financial Results
Intimation · 01 Aug 2026, 5:30 am
Saptak Chem Board Meeting on 1st Aug'26 for Q1 Results & MD Appointment Saptak Chem and Business Limited has scheduled a Board Meeting for 1st Aug'26 to consider and approve its unaudited financial results for the quarter ending 30th Jun'26. The agenda also includes the key appointment of Mr. Ayush Tated as the new Managing Director (MD), subject to shareholder approval. Additionally, the Board will discuss the Director's Report, Secretarial Audit Report for the year ended 31st Mar'26, and finalize details for the upcoming Annual General Meeting (AGM), including book closure dates.
Resignation of Director
Others (Uncategorized) · 21 Jul 2026, 9:59 pm
Saptak Chem Director Resigns, Citing Professional Commitments Saptak Chem and Business Limited announced its Board of Directors accepted the resignation of Mr. Ajay Suresh Yadav (DIN: 09841715) at its meeting on 21st Jul'26. The resignation is effective from 07th Jul'26. Mr. Yadav cited "other professional commitments" as the reason for his departure and confirmed there were no other material reasons for his decision. He will also cease to be a member of all board committees. The company confirmed no relationships exist between Mr. Yadav and other directors.
Change in Registered Office of the Company
Others (Uncategorized) · 25 Jun 2026, 10:35 pm
Saptak Chem Approves Registered Office Relocation in Ahmedabad Saptak Chem and Business Limited's Board of Directors, in a meeting on 25th Jun'26, approved the shifting of its registered office. The office will move from B. D. Patel House, Naranpura to Ashwalekha Complex, Vejalpur Road within Ahmedabad. This change was the key outcome of the board meeting, which concluded at 5:00 p.m.
Reg 32
Others (Uncategorized) · 15 May 2026, 1:33 am
Saptak Chem Confirms No Deviation in Use of Preferential Issue Proceeds Saptak Chem confirms no deviation in utilizing funds from its preferential issue of 40 lakh convertible warrants at ₹10.50 each. The issue, approved at an EGM on 12th Nov'25, has a total potential value of ₹4.20 Cr. The company has received the initial 25% consideration of ₹1.05 Cr, which has been fully utilized for its stated object of meeting working capital requirements. The Audit Committee reviewed the utilization for the period ending 31st Mar'26 and found no variations.
Audited Financial Results along with Auditors Report for the year ended Mar 31, 2026
Financial Result · 14 May 2026, 10:31 pm
SAPTAK CHEM AND BUSINESS LIMITED - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 0.0 ■ EBITDA: -12.5 (-64.6% YoY | -15.2% QoQ) ■ EBITDA Margin (%): 0.0 ■ PAT: -12.5 (-65.6% YoY | -17.4% QoQ) ■ EPS (INR): -1.16 (-1557.1% YoY | -17.2% QoQ)
Audited Financial Results along with Statement of Assets & Liabilities and the Statement of Cash Flow and Auditors Report of the Company for the Quarter and Financial Year ended March 31, 2026.
Outcome · 14 May 2026, 10:23 pm
SAPTAK CHEM AND BUSINESS LIMITED - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 0.0 ■ EBITDA: -12.5 (-64.6% YoY | -15.2% QoQ) ■ EBITDA Margin (%): 0.0 ■ PAT: -12.5 (-65.6% YoY | -17.4% QoQ) ■ EPS (INR): -1.16 (-1557.1% YoY | -17.2% QoQ)
Saptak Chem And Business Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Audited financial ....
Intimation · 14 May 2026, 5:30 am
Saptak Chem Board to Approve Q4 & FY26 Results on 14th May Saptak Chem and Business Ltd (BSE: 506906) has scheduled a Board of Directors meeting on 14th May'26. The primary agenda is to consider and approve the audited financial results for the quarter and financial year ended 31st Mar'26. The board will also review the auditor's report and certificate for an unmodified opinion.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 30 Apr 2026, 5:01 pm
Saptak Chem States It Does Not Qualify as a Large Corporate Saptak Chem and Business Limited (BSE: 506906) informed the exchange on 30-Apr'26 that it does not fall under the "Large Corporate" criteria prescribed by SEBI circular SEBI/HO/DDHS/CIR/P/2018/144. Consequently, the company is not required to furnish the initial disclosure (Annexure-A) related to mandatory fund raising via debt securities. This declaration confirms the non-applicability of the large corporate framework to the company.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HMM Consultancy LLP
Acquisition/ Disposal of Shares · 11 Apr 2026, 4:47 pm
HMM Consultancy LLP Acquires 9.86% Stake in Saptak Chem & Business HMM Consultancy LLP, a non-promoter entity, acquired a 9.86% stake in Saptak Chem and Business Limited through a preferential allotment on 06th Apr'26. The transaction involved 500,000 equity shares at Rs. 10/- face value. Post-acquisition, HMM Consultancy holds 9.86% of the total diluted share capital and 16.27% of the total voting capital. Saptak Chem's equity share capital increased from Rs. 1.07 crore to Rs. 3.07 crore following the allotment.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Akshay Shah HUF
Acquisition/ Disposal of Shares · 10 Apr 2026, 11:18 pm
Akshay Shah HUF Acquires 9.86% Stake in Saptak Chem Akshay Shah HUF, a non-promoter entity, acquired 500,000 equity shares of Saptak Chem and Business Limited on 06 Apr'26 via a preferential allotment. The acquisition represents 9.86% of the company's total diluted share capital and 16.27% of its total voting capital. Following the transaction, Saptak Chem's total diluted share capital increased to 5,073,227 equity shares. Akshay Shah HUF's post-acquisition holding stands at 9.86% of the diluted capital.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ankush Agarwal HUF
Acquisition/ Disposal of Shares · 10 Apr 2026, 11:16 pm
Ankush Agarwal HUF Acquires Stake in Saptak Chem via Preferential Allotment Ankush Agarwal HUF, a non-promoter entity, acquired 5,00,000 shares of Saptak Chem and Business Limited through a preferential allotment. This transaction gives the acquirer a 16.27% stake in the total voting capital and 9.86% of the total diluted share/voting capital. Post-acquisition, the company's total voting capital increased from Rs 1.07 crore to Rs 3.07 crore. The date of receipt of intimation for allotment is noted as 06th Apr'26.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jayshree Jain
Acquisition/ Disposal of Shares · 10 Apr 2026, 11:14 pm
Jayshree Jain Acquires 9.86% Stake in Saptak Chem via Preferential Allotment Jayshree Jain, a non-promoter, acquired 500,000 equity shares of Saptak Chem and Business Limited on 06th Apr'26. This represents 9.86% of the total diluted share capital and 16.27% of the total voting capital. The acquisition was executed via a preferential allotment. Post-acquisition, the company's total diluted share/voting capital stands at 50,73,227 shares, and the equity share capital increased to Rs 3,07,32,270 from Rs 1,07,32,270.
Allotment of 20,00,000 fully paid-up Equity Shares of Rs 10/- each upon conversion of warrants into Equity shares on Preferential Basis
Others (Uncategorized) · 06 Apr 2026, 11:49 pm
Saptak Chem Allots 20 Lakh Equity Shares Via Warrant Conversion On 06 Apr'26, Saptak Chem allotted 20 lakh equity shares of Rs.10 face value upon conversion of warrants on a preferential basis to four non-promoter entities. The conversion was done at an exercise price of Rs.10.50 per share, raising Rs.1.57 crore. This allotment increases the paid-up equity capital from Rs.1.07 crore to Rs.3.07 crore. Following the conversion, 20 lakh warrants remain outstanding. The new shares rank pari passu with existing equity shares, significantly increasing the public float.
Allotment of 20,00,000 fully paid-up Equity Shares of Rupees 10/- each upon conversion of warrants into Equity shares, on Preferential Basis
Others (Uncategorized) · 06 Apr 2026, 11:45 pm
Saptak Chem Allots 2 Mn Equity Shares on Warrant Conversion On 06 Apr'26, Saptak Chem allotted 2 mn equity shares of Rs. 10 each to non-promoter entities upon warrant conversion. The conversion was done at a price of Rs. 10.50 per share, with Rs. 7.875 per share received upon exercise, aggregating to Rs. 1.57 Cr. This action increased the company's paid-up equity capital from Rs. 1.07 Cr to Rs. 3.07 Cr. Following the conversion, 2 mn warrants remain outstanding. The four allottees now collectively hold a 65.08% stake in the company.